Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · IEX Real-Time Price · USD

12.26

+0.21 (1.74%)

At close: Jul 2, 2024, 3:55 PM

12.50

+0.24 (1.96%)

After-hours: Jul 2, 2024, 7:58 PM EDT

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	13	7	47	191	198	238	Upgrade
Market Cap Growth	-2.63%	-84.63%	-75.15%	-3.45%	-16.81%	80.37%	Upgrade
Enterprise Value	-98	-0	54	169	179	226	Upgrade
PE Ratio	-	-0.23	-1.14	-2.26	-3.11	-14.79	Upgrade
PS Ratio	8.74	3.79	2.63	35.37	29.52	35.22	Upgrade
PB Ratio	-0.20	1.00	-4.35	8.27	8.05	11.32	Upgrade
P/FCF Ratio	-0.84	-0.24	-1.77	-2.69	-4.87	-12.26	Upgrade
P/OCF Ratio	-0.84	-0.24	-1.77	-2.69	-4.88	-12.42	Upgrade
EV/Sales Ratio	-60.47	-0.06	2.97	31.33	26.69	33.55	Upgrade
EV/EBITDA Ratio	0.63	0.00	-1.44	-2.10	-2.77	-19.02	Upgrade
EV/EBIT Ratio	0.62	0.00	-1.43	-2.06	-2.70	-14.34	Upgrade
EV/FCF Ratio	3.27	0.00	-2.00	-2.38	-4.40	-11.68	Upgrade
Debt / Equity Ratio	-	-	-1.78	1.42	-	-	Upgrade
Debt / EBITDA Ratio	-	-	-0.52	-0.41	-	-	Upgrade
Debt / FCF Ratio	-	-	-0.72	-0.46	-	-	Upgrade
Quick Ratio	0.51	1.64	0.68	2.99	1.53	1.36	Upgrade
Current Ratio	0.52	1.82	0.74	3.11	1.71	1.46	Upgrade
Asset Turnover	0.03	0.07	0.44	0.07	0.12	0.12	Upgrade
Interest Coverage	-56.89	-8.23	-8.98	-34.37	-	-	Upgrade
Return on Equity (ROE)	586.10%	-1439.90%	1327.60%	-285.70%	-182.30%	-80.30%	Upgrade
Return on Assets (ROA)	-288.30%	-113.90%	-101.60%	-111.40%	-117.40%	-28.20%	Upgrade
Return on Capital (ROIC)	45.61%	-374.47%	-440.42%	-146.89%	-296.57%	-82.84%	Upgrade
Earnings Yield	-1126.95%	-432.44%	-87.80%	-44.19%	-32.11%	-6.76%	Upgrade
FCF Yield	-211.62%	-422.41%	-56.58%	-37.19%	-20.53%	-8.16%	Upgrade
Buyback Yield / Dilution	-1780.17%	-1943.58%	-0.58%	-49.94%	-69.83%	-26.84%	Upgrade
Total Shareholder Return	-1780.17%	-1943.58%	-0.58%	-49.94%	-69.83%	-26.84%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).